Design a biosensor or “early warning system” that reports when a central venous catheter has started to become contaminated and / or is at risk for dangerous complications such as thrombosis (i.e., blood clot formation).
This Challenge requires only a written proposal.
Central venous catheters are long, thin, flexible tubes that are used to administer medications or fluids to hospital patients who are receiving them frequently. These “central lines” may be left in place for a long time (i.e., from weeks to a year). However, despite a cumulative risk of complications over this long time period, there is currently no good way to monitor the condition of a central venous catheter in situ. This challenge asks the solver to design a biosensor that gives a clinical team “early warning” when the condition of a central venous catheter is in jeopardy for a given patient.
This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker.
To receive a full award, the Solvers must transfer to the Seeker their exclusive Intellectual Property (IP) rights to the solution. However, the Seeker may be willing to consider a licensing agreement for a partial award if the Solver cannot transfer an exclusive license to the Seeker.
What is a Theoretical IP Transfer Challenge?
An InnoCentive Theoretical Challenge builds upon an idea but is not yet a proof of concept. A solution to a Theoretical Challenge will solidify the Solver's concept with detailed descriptions, specifications and requirements necessary to bringing a good idea closer to becoming an actual product or service.
This Challenge is a Theoretical-IP Transfer Challenge, meaning that Solvers must relinquish all rights to the Intellectual Property (IP) for which they are awarded. By contrast, Theoretical-Licensing means that the Seeker is requesting non-exclusive rights to use the winning solution. For these forms of a Theoretical Challenge, Solvers that do not win retain the rights to their solution after the evaluation period is complete. The Seeker retains no rights to any IP not awarded.